Organism 105932 -

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Organism Details

Property	Value
Family
Genus
Species
Species authority
Subspecies
Subspecies authority
Comment
Citation	RUSTAN,AC: HALVORSEN,B: HUGGETT,AC: RANHEIM,T: DREVON,CA:. (1997). EFFECT OF COFFEE LIPIDS (CAFESTOL AND KAHWEOL) ON REGULATION OF CHOLESTEROL MATABOLISM IN HEPG2 CELLS.. 17(10)

Experiments

11 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
384081	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism	CAFESTOL
384082	PHARMACOLOGY OF COMPOUND - IN VITRO	LDL(OXIDIZED) UPTAKE INHIBITION	Empty organism	CAFESTOL
384083	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLESTEROL SYNTHESIS STIMULATION	Empty organism	CAFESTOL
384084	PHARMACOLOGY OF COMPOUND - IN VITRO	HMG-CO-A REDUCTASE INHIBITION	Empty organism	CAFESTOL
384085	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PROFILE ALTERATION	Empty organism	CAFESTOL
384086	PHARMACOLOGY OF COMPOUND - IN VITRO	BILE ACID SYNTHESIS STIMULATION	Empty organism	CAFESTOL
384087	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism	KAHWEOL
384088	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLESTEROL SYNTHESIS STIMULATION	Empty organism	KAHWEOL
384089	PHARMACOLOGY OF COMPOUND - IN VITRO	HMG-CO-A REDUCTASE INHIBITION	Empty organism	KAHWEOL
384090	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PROFILE ALTERATION	Empty organism	KAHWEOL
384091	PHARMACOLOGY OF COMPOUND - IN VITRO	BILE ACID SYNTHESIS STIMULATION	Empty organism	KAHWEOL

Show SPARQL Queries (1)